As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

Highmark will start covering a version of Noom — a subscription-based app that claims to enable weight loss by harnessing psychological research — at no cost for nearly 2 million members next year.

The Simple app offers an accessible way to lose weight and improve your overall health. Its personalised plans include ...

The singer's transformation was more apparent than ever as he arrived in Sydney for his first-ever headlining Australian tour Jelly Roll, 40, is nearly unrecognizable after his dramatic 200-lb. weight ...

Arran’s newest business in Blackwaterfoot, Divine Hypnotherapy, has the noble aim of helping people become the “best versions ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

Rachel Woods does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

We recently published 10 Trending Stocks Moving These Days. Novo Nordisk A/S (NYSE:NVO) is one of the trending stocks moving these days. Karen Finerman, CEO & Co-founder, Metropolitan Capital Advisors ...

Weight loss drugs are proving to be super popular among many workers with job-based health insurance. But GLP-1 medications are busting their employers’ budgets, leading some firms to rethink their ...